{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 457812269
| IUPAC_name = (2R,3R,4R,5S,6R)-5-amino-2- [((1R,2R,3R,4R,6R,8R)-8-amino-9- [(1R,2S,3R,4R,6R)-4,6-diamino-2,3- dihydroxy-cyclohexyl]oxy-2-hydroxy- 3-methylamino-5,10- dioxabicyclo[4.4.0]dec-4-yl)oxy]-6- (hydroxymethyl)oxane-3,4-diol
| image = Apramycin.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|apramycin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 37321-09-8
| CAS_supplemental =  
| ATCvet = yes
| ATC_prefix = A07
| ATC_suffix = AA92
| ATC_supplemental =  {{ATCvet|J01|GB90}} {{ATCvet|J51|GB90}}
| PubChem = 3081545
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04626
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2339128
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 388K3TR36Z
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02322
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 2790
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1230961

<!--Chemical data-->
| chemical_formula =  
| C=21 | H=41 | N=5 | O=11 
| molecular_weight = 539.58 g/mol
| smiles = O3[C@H](O[C@H]1O[C@H](CO)[C@@H](N)[C@H](O)[C@H]1O)[C@@H](NC)[C@@H](O)[C@H]4O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O)[C@H](N)C[C@H]34
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XZNUGFQTQHRASN-XQENGBIVSA-N
}}

'''Apramycin''' (also ''Nebramycin II'') is an [[aminoglycoside]] [[antibiotic]] used in veterinary medicine.  It is produced by ''[[Streptomyces]] tenebrarius''.<ref>{{cite journal|author1=R. Ryden|author2=B. J. Moore|title=The ''in vitro'' activity of apramycin, a new aminocyditol antibiotic|journal=J Antimicrob Chemother|year=1977|volume=3|issue=6|pages=609–613|doi=10.1093/jac/3.6.609|pmid=340441}}</ref>

==Spectrum of bacterial susceptibility and resistance==
Apramycin can be used to treat bacterial infections in animals caused by ''Escherichia coli, Klebsiella pneumoniae'', and ''Pseudomonas aeruginosa''. The following shows susceptibility data on medically significant organisms:
* Escherichia coli - 1 μg/mL - >512 μg/mL (this large range may be due to resistant organisms, typical MIC values are likely in the range of 2 -8 μg/mL.
* Klebsiella pneumoniae - 2 μg/mL - >256 μg/mL
* Pseudomonas aeruginosa - 4 μg/mL
<ref>http://antibiotics.toku-e.com/antimicrobial_1728.html</ref>

== References ==
{{Reflist}}

{{AminoglycosideAntiBiotics}}

[[Category:Aminoglycoside antibiotics]]